Prostate cancer screening and bacteraemia-Reference-Cited by-同舟云学术

Prostate cancer screening and bacteraemia

Published:2008-01 Issue:1 Volume:188 Page:60-60
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Bowden Francis J¹,Roberts Jan²,Collignon Peter J²

Affiliation:

1. Academic Unit of Internal Medicine, Australian National University, Canberra Hospital, Canberra, ACT.

2. Infectious Diseases Unit and Microbiology Department, Canberra Hospital, Canberra, ACT.

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.2008.tb01513.x

Reference5 articles.

1. Screening for prostate cancer

2. SAFETY AND MORBIDITY OF FIRST AND REPEAT TRANSRECTAL ULTRASOUND GUIDED PROSTATE NEEDLE BIOPSIES: RESULTS OF A PROSPECTIVE EUROPEAN PROSTATE CANCER DETECTION STUDY

3. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia

4. Medicare Australia.Medicare Benefits Schedule (MBS) item statistics reports.http://www.medicareaustralia.gov.au/statistics/dyn_mbs/forms/mbs_tab4ag.shtml(accessed Oct 2007).

5. Screening for prostate cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The state of TRUS biopsy sepsis: readmissions to Victorian hospitals with TRUS biopsy-related infection over 5 years;BJU International;2015-10

2. Should we screen for prostate cancer? A re‐examination of the evidence;Medical Journal of Australia;2013-06

3. Multifocal abscesses due to multiresistant Escherichia coli after transrectal ultrasound‐guided prostate biopsy;Medical Journal of Australia;2013-03